Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

CJC-1295 DAC 2mg & Ipamorelin 5mg Dosage Chart - Peptide Dosages

CJC-1295 DAC (2 mg Vial) & Ipamorelin (5 mg Vial) Dosage Protocol GHRH analog (CJC-1295 DAC) + ghrelin-receptor GH secretagogue (Ipamorelin) — two separate research-only vials; the combination is not clinically validated. Mix & measure CJC-1295 DAC + Ipamoreli

CJC-1295 DAC (2 mg Vial) & Ipamorelin (5 mg Vial) Dosage Protocol

GHRH analog (CJC-1295 DAC) + ghrelin-receptor GH secretagogue (Ipamorelin) — two separate research-only vials; the combination is not clinically validated.

Mix & measure CJC-1295 DAC + Ipamorelin · 2 mg

Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →

Dosing & Reconstitution Guide

Each peptide reconstituted in its own vial — CJC-1295 DAC dosed in mg, Ipamorelin in mcg

CJC-1295 DAC (2 mg Vial): Standard / Gradual Approach (1 mL = 2 mg/mL)

Reconstitute: Add 1.0 mL bacteriostatic water to the 2 mg vial → final concentration 2 mg/mL (20 mcg/unit). Each full vial = 2 mg total.

Typical weekly total: 1 mg per week, given as one injection (or split into 2).

Easy measuring: At 2 mg/mL, 0.5 mg ≈ 25 units (0.25 mL) and 1 mg ≈ 50 units (0.5 mL) on a U-100 syringe.

Weeks 1–4

1 mg/week

1 mg

~0.5 mL (50 units)

1× per week

To split for smoother IGF-1 levels, administer 0.5 mg (25 units) twice weekly.

CJC-1295 DAC (2 mg Vial): Advanced / Aggressive Approach (1 mL = 2 mg/mL)

Reconstitute: Add 1.0 mL bacteriostatic water to the 2 mg vial → 2 mg/mL (20 mcg/unit). The full vial delivers a single 2 mg weekly dose.

Easy measuring: At 2 mg/mL, 2 mg ≈ 100 units (1 mL) and 1 mg ≈ 50 units (0.5 mL) on a U-100 syringe.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

CJC-1295 WITH DAC 2MG — Research Grade

C165H271N47O46S 3647.2 g/mol 863288-34-0 ES-CJCD-2 CJC-1295 with DAC incorporates a maleimidoproprionic acid (MPA) side chain enabling covalent binding to serum albumin in solution. This albumin-binding mechanism substantially extends the compound half-life in research models compared to unmodified GHRH or CJC-1295 No DAC. Used in research examining continuous versus pulsatile GHRH receptor stimulation protocols and differential downstream signalling outcomes associated with prolonged versus intermittent GHRHR activation in cell-based assay models. Its extended activity profile makes it a useful comparator in studies designed to distinguish acute from chronic receptor engagement effects. Element SARMs supplies CJC-1295 with DAC at 2mg per vial. USA-manufactured and verified at 99%+ purity by HPLC and Mass Spectrometry. Reconstitute with bacteriostatic water. Store at -20C. WARNING: For research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. For use by qualified research professionals only.

RESEARCH

Research Liquids

Albuterol 5MG/ML | 30ML with dropper Anastrozole 1.5MG/ML | 30ML with dropper Clomiphene 50MG/ML | 30ML with dropper Finasteride 5MG/ML | 30ML with dropper Letrozole 3.5 MG/ML | 30ML with dropper LiquiCia 30MG/ML | 30ML with dropper LiquiCia T50 50MG/ML | 30ML with dropper LiquiClen 200MCG/ML | 30ML with dropper Liquistane / Exemestane 25MG/ML | 30ML with dropper LiquiTamo 20MG/ML | 30ML with dropper LiquiVia 25MG/ML | 30 ML with dropper T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper Toremifene Citrate 60MG/ML | 30ML with dropper Yohimbine HCL 10MG/ML | 30ML with dropper